


Poster: Tumor homology with self as a biomarker for response to checkpoint inhibitor therapy
EpiVaxTx_SITC22_Melanoma_28Oct22_56Wx31.5H
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
